Scalpel Weekly News

Week of: July 24, 2017

IN THE NEWS


Gene Therapy To Cure Resistant/Relapsed Leukemia

On July 14, 2017, the FDA’s Oncologic Drugs Advisory Committee recommended the FDA approve the application from Novartis Pharmaceuticals Corporation for Tisagenlecleucel, a treatment for B-cell acute lymphoblastic leukemia that has resisted treatment, or relapsed, in children and young adults between the ages of 3 and 25. Click title to continue reading...


 
MEDICAL ALERTS


Risk of Inaccurate Results from Blood Lead Testing Systems

On July 13, 2017, the FDA updated the Class I recall issued for all serial numbers and all lot numbers of LeadCare Plus and Ultra Testing Systems. Magellan’s LeadCare Plus and Ultra Testing Systems were two of four blood lead testing systems affected by recommendations in an FDA safety communication. Click title to continue reading...



Pain Management and Prescription Opioid Abuse Strategy

On July 15, 2017, FDA Commissioner Scott Gottlieb, M.D., issued a statement regarding the National Academies of Sciences, Engineering, and Medicine (NASEM) report on pain management and prescription opioid abuse. In March 2016, the FDA asked NASEM to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management. Click title to continue reading...



Harmful Increasing Waterbody Algal Blooms Are Nationwide Threat

On July 12, 2017, the CDC published information about harmful algal blooms. Harmful algal blooms can produce toxins that are dangerous to people, animals, and the environment. Harmful algal blooms have occurred in every region of the United States. In 2014, 38 states responded to a survey about harmful algal blooms, and more than half reported that such blooms occur every year in a freshwater body. Click title to continue reading...


  CASE ALERTS


Trial Court May Modify Verdict If Grounds Stated and Explained

A husband and wife were passengers in a taxicab when it collided with another vehicle. The husband and wife were injured. Specifically, the husband sustained multiple fractures to the dominant arm and underwent surgery to permanently implant a plate and screws to stabilize it. Click title to continue reading...



Expert Needed for Failure to Communicate Blood Testing Need

A man presented to the hospital complaining of shortness of breath and leg swelling. The attending physician placed the man on blood thinners, including heparin and warfarin, because the attending physician suspected a pulmonary embolism. The attending physician ordered the man to undergo daily blood clotting tests. Click title to continue reading...



Judgment Must Be Satisfied Before Equitable Subrogation

A man sustained head injuries when riding a scooter that collided with a car. The car belonged to the driver’s father. The man received medical treatment at a hospital. At the hospital, the man’s injuries were exacerbated by medical negligence. Click title to continue reading...


FEATURE


Interview Checklist: Negligence Involving Repeat Brain Injury/CTE

As a special feature for our Premium subscribers we have included this feature containing an illustrative checklist for litigation involving repeat brain injury, resulting in chronic traumatic encephalopathy (CTE). In this illustrative situation, a student-athlete sustained multiple concussive head injuries while playing football. Click title to continue reading...